Stephen G Rostand
Affiliation: University of Alabama at Birmingham
- Racial disparities in the association of foetal growth retardation to childhood blood pressureStephen G Rostand
Division of Nephrology, University of Alabama at Birmingham, 1530 3rd Avenue South, Birmingham, AL 35294, USA
Nephrol Dial Transplant 20:1592-7. 2005..For this reason we re-examined the role of FGR in childhood blood pressure...
- Racial differences in renal arteriolar structure in children with minimal change nephropathyStephen G Rostand
Nephrology Research and Training Center, Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama 35223, USA
Kidney Int 68:1154-60. 2005..The aim of this study was to determine if renal vascular changes were more pronounced in African Americans, were independent of blood pressure, and occurred in early childhood...
- Introduction to Vitamin D Symposium, March 14, 2008Stephen G Rostand
Division of Nephrology, University of Alabama at Birmingham, AL 35294, USA
Clin J Am Soc Nephrol 3:1534. 2008....
- Vitamin D, blood pressure, and African Americans: toward a unifying hypothesisStephen G Rostand
The Nephrology Research and Training Center, Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA
Clin J Am Soc Nephrol 5:1697-703. 2010....
- The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertensionJanice Lea
Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA
Arch Intern Med 165:947-53. 2005..CONCLUSIONS: The change in the level of proteinuria is a predictor of subsequent progression of hypertensive kidney disease at a given GFR. A prospective trial is needed to confirm this observation...
- Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trialJackson T Wright
Case Western Reserve University, Department of Medicine, University Hospitals of Cleveland and the Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, OH 44106 5014, USA
JAMA 288:2421-31. 2002..Hypertension is a leading cause of end-stage renal disease (ESRD) in the United States, with no known treatment to prevent progressive declines leading to ESRD...
- Oligonephronia, primary hypertension and renal disease: 'is the child father to the man?'Stephen G Rostand
Nephrol Dial Transplant 18:1434-8. 2003
- The rationale and design of the AASK cohort studyLawrence J Appel
Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Medical Institutions, Baltimore, Maryland, 21205, USA
J Am Soc Nephrol 14:S166-72. 2003..Such results might eventually lead to new strategies that delay or prevent ESRD...
- Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African AmericansLawrence J Appel
Welch Center for Prevention, Epidemiology, and Clinical Research, The Johns Hopkins Institutions, Johns Hopkins University, Baltimore, MD 21205 2223, USA
Arch Intern Med 168:832-9. 2008..A low blood pressure (BP) goal (BP, <130/80 mm Hg) is also recommended. The objective of this study was to determine the long-term effects of currently recommended BP therapy in 1094 African Americans with hypertensive CKD...